Ixabepilone
Back to searchMolecule Structure
Scientific Name
Ixabepilone
Description of the Drug
Ixabepilone is a microtubule inhibitor administered in combination with capecitabine or alone in the treatment of metastatic or locally advanced breast cancer that has shown inadequate response to taxanes and anthracyclines.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB04845
http://www.drugbank.ca/drugs/DB04845
Brand Name(s)
Ixempra, Ixempra kit
Company Owner(s)
R-Pharm Us Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Tubulin | PROTEIN COMPLEX GROUP | INHIBITOR | CHEMBL2095182 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL8386 | |
| DrugBank | DB04845 | |
| PubChem: Thomson Pharma | 14933557 | 14786763 |
| PubChem | 6445540 | |
| LINCS | LSM-43293 | |
| Nikkaji | J1.408.120H | |
| PDBe | GZX | |
| EPA CompTox Dashboard | DTXSID70870252 | |
| DrugCentral | 1517 | |
| ChemicalBook | CB61011739 | |
| Guide to Pharmacology | 6824 | |
| rxnorm | IXEMPRA | IXABEPILONE |
| PubChem: Drugs of the Future | 49684213 | |
| ChEBI | 63605 | |
| ZINC | ZINC000003993846 |
